Armata Pharmaceuticals, Inc. (ARMP)
11.06
+1.52
(+15.93%)
USD |
NYAM |
Feb 24, 13:14
Armata Pharmaceuticals EPS Diluted (Quarterly) : -0.7363 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.68M |
| Revenue (Quarterly) | 1.159M |
| Total Expenses (Quarterly) | 27.83M |
| Enterprise Value | 510.25M |
| Gross Profit Margin (Quarterly) | 68.08% |
| Profit Margin (Quarterly) | -2.30K% |
| Earnings Yield | -11.96% |
| Normalized Earnings Yield | -11.05 |